Discussions are underway ahead of the 25-26 March EU summit to modify the distribution mechanism for the advance delivery of Covid-19 vaccine doses from Pfizer-BioNTech(see EUROPE B12679A1).
According to the Financial Times, the EU is considering allocating part of this envelope (30%) to the Member States most affected by the virus, rather than distributing it in proportion to the population of the Member States.
According to the British newspaper, this solution is widely supported by...